HomeInsightsPB

Shilpa Medicare Ltd PB Ratio

Shilpa Medicare Ltd PB Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

0.4 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

PB

3.6

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Shilpa Medicare Ltd is 3.6 as of 07 Nov 24.
  • The P/B Ratio of Shilpa Medicare Ltd changed from 1.9 on March 2022 to 2.2 on March 2024 . This represents a CAGR of 5.01% over 3 years. .

Historical P/B Ratio of Shilpa Medicare Ltd

No data available

Company Fundamentals for Shilpa Medicare Ltd

Market Cap

8,247 Cr

EPS

4.2

P/E Ratio (TTM) *

200.8

P/B Ratio (TTM) *

3.6

Day’s High *

846.25

Day’s Low

837.95

DTE *

0.5

ROE *

1.7

52 Week High

959.95

52 Week Low

313.55

ROCE *

5.1

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024843.4
06 Nov 2024846.6
05 Nov 2024834.35
04 Nov 2024818.6
01 Nov 2024842.3
31 Oct 2024842.35
30 Oct 2024843.1
29 Oct 2024799.95
28 Oct 2024804.25
25 Oct 2024783.25

SWOT Analysis Of Shilpa Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Shilpa Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Shilpa Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Shilpa Medicare Ltd38,247
Sun Pharmaceuticals Industries Ltd994,29,841
Divis Laboratories Ltd5161,58,179
Cipla Ltd3621,27,063
Mankind Pharma Ltd2651,09,234
Dr Reddys Laboratories Ltd3191,07,398

Key Valuation Metric of Shilpa Medicare Ltd

Share Price

₹838

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Revenue of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical EBITDA of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Shilpa Medicare Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Shilpa Medicare Ltd News Hub

News

Shilpa Medicare schedules board meeting

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 13 Novembe...

Read more

04 Nov 202418:42

News

Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility

In a regulatory filing made during market hours today, the company informed the company's ...

Read more

31 Oct 202413:43

News

Shilpa Medicare arm gets CEP from EDQM for Desmopressin

Desmopressin is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid...

Read more

04 Oct 202408:40

News

Shilpa Medicare announces receipt of CEP from EDQM for API 'Desmopressin'

Shilpa Medicare's 100% subsidiary, Shilpa Pharma Lifesciences received certificate of suit...

Read more

03 Oct 202417:12

News

Shilpa Medicare arm appoints Sridevi Khambhampaty as CEO

Sridevi Khambhampaty y is a recognized leader in the Biologics industry with over two deca...

Read more

19 Sep 202413:35

News

Shilpa Biologicals appoints CEO

Shilpa Medicare announced the appointment of Dr. Sridevi Khambhampaty, as Chief Executive ...

Read more

19 Sep 202413:35

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Shilpa Medicare Ltd

What is the PB ratio of Shilpa Medicare Ltd?

The current PB ratio of Shilpa Medicare Ltd is 3.57. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Shilpa Medicare Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Shilpa Medicare Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Shilpa Medicare Ltd calculated?

The PB ratio of Shilpa Medicare Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Shilpa Medicare Ltd?

A high PB ratio suggests that Shilpa Medicare Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Shilpa Medicare Ltd?

A low PB ratio of Shilpa Medicare Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Shilpa Medicare Ltd PB Ratio change over time?

Yes, the PB ratio of Shilpa Medicare Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*